• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Adar Poonawalla sells stake in Panacea Biotec

expresspharmaMay 19, 2021

Tag: Adar , SII , Panacea Biotec

Adar Poonawalla, CEO, Serum Institute of India (SII) has sold off his entire stake of 31,57,034 shares in Panacea Biotec at a price of Rs 373.85 apiece. He had a 5.15 per cent shareholding in the company and the total value of the transaction was a little over Rs 118 crores. The stake was picked up by SII.

PTI reported that as per shareholding data for March quarter, Poonawalla and SII were public shareholders in the company. They held 5.15 per cent and 4.98 per cent stake respectively in Panacea Biotec.

Previous:Good News in the Chinese Diabetes Field and Several Original Research Drugs Underway

Next:Boehringer Ingelheim allocates one million Euros to fight COVID-19 in India

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Adar Poonawalla sells stake in Panacea Biotec | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

elder Sambucus williamsii Sambucus nigra Williams Elder Twig elderberry extract elder Sambucus willi

elder Sambucus williamsii Sambucus nigra Williams Elder Twig elderberry extract elder Sambucus willi
100%Nutramax Supplier -sambucus williamsii hance extract10:1

100%Nutramax Supplier -sambucus williamsii hance extract10:1
Cosmosiin 98%

Cosmosiin 98%
Losartan potassium (ProcessII)

Losartan potassium (ProcessII)
Herba Cirsii Extract

Herba Cirsii Extract
(+)-Rabdosiin

(+)-Rabdosiin
PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL
GENTAMYCIN SULPHATE macrolides

GENTAMYCIN SULPHATE macrolides
CEFALEXINE cephalosporins

CEFALEXINE cephalosporins

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service